IRON$78.582.80%-2.26
After Hours: 78.62+0.04 +0.05%
Disc Medicine Inc (IRON)
Date: 2026-11-02 16:00O: 80.99H: 81.69L: 78.04C: 78.58Vol: 340.6k
Disc Medicine Inc stock is traded at $78.58, with a volume of 340,592. It is down -2.80% in the last 24 hours and up +21.81% over the past month. Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
Previous Close:
$80.84
Open:
$80.99
24h Volume:
340,592
Relative Volume:
0.21
Market Cap:
$3.49B
Revenue:
-
Net Income/Loss:
-$241.60M
P/E Ratio:
-
EPS:
-$6.62
Net Cash Flow:
-$201.34M
1W Performance:
+1.18%
1M Performance:
+21.81%
6M Performance:
+17.44%
1Y Performance:
-8.86%
1-Day Range:
$78.04$81.69
1-Week Range:
$76.50$85.00
52-Week Range:
$40.00$99.50
Disc Medicine Inc Stock (IRON) Company Profile
Name
Disc Medicine IncSector
HealthcareIndustry
BiotechnologyPhone
(617) 674-9274Address
321 ARSENAL STREET, SUITE 101, WATERTOWN, USACompare IRON vs VRTX, REGN, MRNA, ARGX, ONC
| Stocks | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|
IRON Disc Medicine Inc | $3.49B | $0 | -$245.89M | -$197.58M | -$6.62 |
 VRTX Vertex Pharmaceuticals Inc | $140.94B | $12.59B | $4.41B | $3.80B | $16.87 |
 REGN Regeneron Pharmaceuticals Inc | $99.46B | $16.90B | $4.82B | $3.83B | $41.04 |
 MRNA Moderna Inc | $88.17B | $2.23B | -$3.15B | -$1.24B | -$8.15 |
 ARGX Argen X Se Adr | $55.03B | $4.16B | $1.29B | $734.26M | $19.58 |
 ONC Beone Medicines Ltd Adr | $40.86B | $6.13B | $655.71M | $1.33B | $4.48 |
Disc Medicine Inc Stock (IRON) Upgrades & Downgrades
Disc Medicine Inc Stock (IRON) Financials Data
Disc Medicine Inc Stock (IRON) Insider Trading
- Bitterman KevinOct 21 '26Director
- Transaction
- Sale
- Cost
- $80.23
- #Shares
- 25,519
- Value ($)
- 2,047,389
- #Shares Total
- 12,991
- Atlas Venture Opportunity FundOct 21 '26Shareholder
- Transaction
- Proposed Sale
- Cost
- $79.48
- #Shares
- 11,470
- Value ($)
- 911,636
- #Shares Total
- 0
- Atlas Venture Opportunity FundOct 21 '26Shareholder
- Transaction
- Proposed Sale
- Cost
- $79.48
- #Shares
- 13,783
- Value ($)
- 1,095,473
- #Shares Total
- 0
- Atlas Venture Fund X, LPOct 21 '26Shareholder
- Transaction
- Proposed Sale
- Cost
- $79.48
- #Shares
- 33,461
- Value ($)
- 2,659,480
- #Shares Total
- 0
- Atlas Venture Fund XII, LPOct 21 '26Shareholder
- Transaction
- Proposed Sale
- Cost
- $79.48
- #Shares
- 266
- Value ($)
- 21,142
- #Shares Total
- 0
- Bitterman KevinOct 20 '26Director
- Transaction
- Sale
- Cost
- $79.95
- #Shares
- 5,312
- Value ($)
- 424,694
- #Shares Total
- 13,257
- Atlas Venture Opportunity FundOct 20 '26Shareholder
- Transaction
- Proposed Sale
- Cost
- $78.93
- #Shares
- 2,388
- Value ($)
- 188,485
- #Shares Total
- 0
- Atlas Venture Fund X, LPOct 20 '26Shareholder
- Transaction
- Proposed Sale
- Cost
- $78.93
- #Shares
- 6,965
- Value ($)
- 549,747
- #Shares Total
- 0
- Atlas Venture Opportunity FundOct 20 '26Shareholder
- Transaction
- Proposed Sale
- Cost
- $78.93
- #Shares
- 2,869
- Value ($)
- 226,450
- #Shares Total
- 0
- Atlas Venture Fund XII, LPOct 20 '26Shareholder
- Transaction
- Proposed Sale
- Cost
- $78.93
- #Shares
- 55
- Value ($)
- 4,341
- #Shares Total
- 0
